Atlas Trials

Local Therapies for Oligometastatic Non-Small Cell Lung Cancer Harboring Sensitizing EGFR Mutations

Clinical trial NCT02450591 · COMPLETED

Trial details

NCT number
NCT02450591
Sponsor
Memorial Sloan Kettering Cancer Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Oligometastatic Lung Adenocarcinoma
Start date
2015-05-14
Primary completion
2017-12-11
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.